Effectiveness of Sofosbuvir-Based Therapy in Chronic Hepatitis C Patients: A Clinical Study from Abbottabad, KPK Pakistan
Pakistan Journal of Gastroenterology · 22.05.2026 · 42 (1) · 864-868
DOI: 10.63521/pjg.42.1.2026.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan Journal of Gastroenterology, online erschienen am 22.05.2026. Verfasst von Dr Saifullah khan. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatitis C Virus (HCV) infection is a significant public health issue in Pakistan. Direct acting antivirals (DAAs) particularly sofosbuvir based regimens have demonstrated high efficacy in achieving sustained virologic response (SVR). This observational study included 350 patients diagnosed with chronic hepatitis HCV infection between July 2024 to september 2025. Among 350 patients 190 were male and 160 were female age ranges from 16 to 68 years. After PCR all patients were put on sofosbuvir 400 mg for 12 weeks. Out of 190 male patients 175 (92%) achieved SVR12 while 152 (95 %) female achieved SVR12 after 12 weeks treatment.
Zitieren
APA
khan, D. S. (2026). Effectiveness of Sofosbuvir-Based Therapy in Chronic Hepatitis C Patients: A Clinical Study from Abbottabad, KPK Pakistan. Pakistan Journal of Gastroenterology, 42(1), 864-868. https://doi.org/10.63521/pjg.42.1.2026.29
Vancouver
khan DS. Effectiveness of Sofosbuvir-Based Therapy in Chronic Hepatitis C Patients: A Clinical Study from Abbottabad, KPK Pakistan. Pakistan Journal of Gastroenterology. 2026;42(1):864-868. doi:10.63521/pjg.42.1.2026.29
BibTeX
@article{khan2026,
author = {khan, Dr Saifullah},
title = {Effectiveness of Sofosbuvir-Based Therapy in Chronic Hepatitis C Patients: A Clinical Study from Abbottabad, KPK Pakistan},
journal = {Pakistan Journal of Gastroenterology},
year = {2026},
volume = {42},
number = {1},
pages = {864--868},
doi = {10.63521/pjg.42.1.2026.29}
}
EUVIMED